Article citationsMore>>

Coté, T.R., Mohan, A.K., Polder, J.A., Walton, M.K. and Braun, M.M. (2015) Botulinum Toxin Type A Injections: Adverse Events Reported to the US Food and Drug Administration in Therapeutic and Cosmetic Cases. Journal of the American Academy of Dermatology, 53, 407-415.
https://doi.org/10.1016/j.jaad.2005.06.011

has been cited by the following article:

• TITLE: Severe Botulism after Intragastric Botulinum Toxin-A Injection: A Case Series

  AUTHORS: Sadiye Gumusyayla, Gonul Vural

  KEYWORDS: Intragastric Botulismus Toxin-A, Botulism, Single Fiber Electromyography

  JOURNAL NAME: World Journal of Neuroscience, Vol.14 No.2, March 29, 2024

  ABSTRACT: Intragastric botulismus toxin-A (BoNT-A) is one of the new approaches in the treatment of obesity. We aimed to contribute to the literature by presenting the clinical features, laboratory findings and treatment responses of iatrogenic botulism cases due to intragastric BoNT-A administered in our clinic. All detailed medical information was obtained by accessing the medical records of the patients who were hospitalized and followed up and treated between September 2022 and December 2022, and the diagnosis of A.05.1 Botulism was entered according to ICD-10, and whose clinical findings were compatible with botulism disease and who underwent intragastric BoNT-A application beforehand. These records were obtained by examining this information. 10 patients who developed botulism after intragastric BoNT-A application between 01/09/2022 and 28/02/2023 were followed up in our clinic. All of the patients were women. The mean age was 35. The mean hospital stay was 9 days. Only 1 of our cases required intensive care. Good response to treatment was accepted as a complete or near-complete improvement in the clinical findings of the patients and all of them had a good response to treatment. Intragastric BoNT-A administration is a procedure that requires careful indication with a profit/loss calculation considering the potential side effects. In addition, attention should be paid to dilution rates and dose amounts.